NAS:VRCA (USA) Also Trade In: Germany
Verrica Pharmaceuticals Inc $ 8.27 0.12 (1.47%)
Warning! GuruFocus has detected 2 Severe warning signs with VRCA. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Verrica Pharmaceuticals Inc () from 2018 to Sep 28 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Verrica Pharmaceuticals stock (VRCA) PE ratio as of Sep 28 2020 is 0. More Details
Verrica Pharmaceuticals PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Verrica Pharmaceuticals PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:CDMO NAS:UROV NAS:VSTM NAS:CNCE NAS:CDXC NAS:EVFM NAS:OSMT NAS:CHMA NAS:TCRR NAS:CBMG OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Address 10 North High Street, Suite 200, West Chester, PA, USA, 19380
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.